Phio Pharmaceuticals (PHIO) Other Operating Expenses (2012 - 2023)
Phio Pharmaceuticals' (PHIO) quarterly Other Operating Expenses came in at $126000.0 in Q4 2023, up 101.89% on a QoQ basis from -$6.7 million in Q4 2021.
Phio Pharmaceuticals (PHIO) Other Operating Expenses (2012 - 2023) Analysis & Trends
Phio Pharmaceuticals (PHIO) has 5 years of Other Operating Expenses data on file, last reported at $126000.0 in Q4 2023.
- Quarterly Other Operating Expenses changed N/A year-over-year to $126000.0 in Q4 2023, while the trailing twelve-month figure through Sep 2024 was $126000.0 (changed N/A YoY) and the FY2023 annual result came in at $126000.0, changed N/A from the prior year.
- Other Operating Expenses climbed to $126000.0 in Q4 2023, from -$6.7 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $126000.0 in Q4 2023 to a low of -$6.7 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Phio Pharmaceuticals | 14.06 Mn | 14.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 126,000.00 |
| Dec 31, 2021 | -6.66 Mn |
| Jun 30, 2017 | 85,000.00 |
| Mar 31, 2017 | 4.61 Mn |
| Mar 31, 2013 | -473,000.00 |
| Dec 31, 2012 | -650,000.00 |
| Sep 30, 2012 | -387,000.00 |
| Mar 31, 2012 | -537,000.00 |